Qualigen Therapeutics rises on U.S. patent for cancer drug

Aixcrypto Holdings

21/03/2023 15:12

(Updates)
    ** Shares of biotech company Qualigen Therapeutics Inc
 QLGN.O  rise 8.2% to $1.06 after patent for cancer drug
    ** Stock set for biggest one-day pct gain in two weeks if
gains hold 
    ** Patent protects composition of matter for QN-302, QLGN's
experimental drug to treat solid tumors, including pancreatic
cancer - co
    ** It also offers exclusivity to the company into 2040     
    ** QLGN says it has also received a similar patent in the EU
    ** Stock has fallen ~82% in the past 12 months

 (Reporting by Mariam Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))